Prospective pilot study with [89Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE)
L. Campion, Françoise Kraeber‐Bodéré, Nageh K. Allam, A. Rauscher et al.
Citations
1 citations
Journal
European Journal of Nuclear Medicine and Molecular Imaging
Topics
Medical Imaging Techniques and Applications
Field-Weighted Citation Impact (FWCI)
1.36
article
Prospective pilot study with [89Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE)
L. Campion, Françoise Kraeber‐Bodéré, Nageh K. Allam, A. Rauscher, Luis García Ferrer, A. Morel, J.S. Frenel, Caroline Rousseau, Mario Campone, Darian Rusu, Laurence Vilcot, M Heyman, M. Robert, Manon Taupin
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
European Journal of Nuclear Medicine and Molecular ImagingVol. 53(4)
Institutions
Centre National de la Recherche Scientifique (FR), Inserm (FR), Université Nantes Angers Le Mans (FR), Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers (FR), Institut de Cancérologie de l'Ouest (FR), Unité en Sciences Biologiques et Biotechnologies de Nantes (FR), Nantes Université (FR)